Pharmaceuticals

Celiac Disease Treatment Market Outlook 2026–2030 with Key Growth Drivers

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Celiac Disease Treatment Market From 2026 To 2030?

The celiac disease treatment market has experienced substantial growth over recent years. Its value is projected to rise from $0.66 billion in 2025 to $0.72 billion in 2026, marking a compound annual growth rate (CAGR) of 9.3%. This historical growth can be linked to factors such as limited pharmaceutical treatment options, a strong dependence on gluten-free diet management, increasing rates of diagnosis, heightened awareness regarding autoimmune disorders, and improved accessibility of diagnostic testing.

The celiac disease treatment market is projected to experience significant expansion in the coming years, reaching a size of $1.03 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period can be attributed to several factors, including the advancement of non-dietary therapeutic choices, the broadening of enzyme and immunotherapy pipelines, an increasing global prevalence of celiac disease, enhanced diagnostic accuracy, and a rise in healthcare spending on chronic autoimmune conditions. Key trends anticipated in the forecast period involve a greater adoption of gluten-free dietary management, the ongoing development of enzyme-based therapies, an intensified focus on early diagnosis and screening, the diversification of nutritional supplement-based treatments, and increased patient awareness and education regarding the disease.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Celiac Disease Treatment Market?

The future expansion of the celiac disease treatment market is expected to be propelled by the growing incidence of diabetes. Diabetes is a chronic medical condition characterized by the body’s inability to properly regulate blood sugar or glucose levels. The increasing occurrence of diabetes is linked to shared dietary management requirements, as both diabetes and celiac disease demand careful control of food intake to manage blood sugar levels and prevent complications. Celiac disease treatment supports diabetes management through the promotion of a gluten-free diet, which can lead to improvements in overall digestive health and nutrient absorption. This approach helps achieve better blood sugar control and minimizes complications for individuals managing both conditions. For instance, in June 2024, according to the National Health Service, a UK-based government department, around 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of diabetes is a significant driver for the celiac disease treatment market.

Which Segments Are Included In The Analysis Of The Celiac Disease Treatment Market?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies

Which Trends Are Impacting The Growth Of The Celiac Disease Treatment Market?

Companies operating within the celiac disease treatment market are concentrating on developing oral therapies, including small molecule treatments. These initiatives aim to deliver targeted relief by blocking immune reactions to gluten, improving patient compliance, and presenting alternatives to strict gluten-free diets. Small molecule therapies are diminutive drugs designed to readily enter cells to target and address proteins or enzymes responsible for disease. As an illustration, in February 2025, Immunic Inc., a US-based biotechnology company, launched IMU-856. IMU-856 is a small molecule that increases natural glucagon-like peptide-1 (GLP-1) levels, which helps enhance intestinal barrier function in celiac disease patients. This also facilitates improved nutrient absorption and alleviates symptoms without inhibiting immune system activity.

Which Key Industry Participants Are Active In The Celiac Disease Treatment Market?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Read the full celiac disease treatment market report here:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

What Are The Leading Geographic Regions In The Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Celiac Disease Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2026, By The Business Research Company

Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Crohns Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795